@article{ec70486db8424730a2307b1b5f37ed09,
title = "Heavy chain disease: Our experience",
abstract = "Heavy chain disease (HCD) is a rare lymphoproliferative disorder of plasma cells, described for the first time in 1964 by Franklin [1], characterized by production of incomplete monoclonal immunoglobulin heavy chains without associated light chains [2].",
keywords = "Biochemistry (medical), Clinical Biochemistry, heavy chain disease, immunofixation electrophoresis, immunoselection, Biochemistry (medical), Clinical Biochemistry, heavy chain disease, immunofixation electrophoresis, immunoselection",
author = "Francesca Gulli and Cecilia Napodano and Krizia Pocino and Annarosa Cuccaro and Stefan Hohaus and Umberto Basile",
year = "2017",
doi = "10.1515/cclm-2017-0254",
language = "English",
volume = "56",
pages = "e10--e12",
journal = "Clinical Chemistry and Laboratory Medicine",
issn = "1434-6621",
publisher = "Walter de Gruyter and Company:Genthinerstrasse 13, D 10785 Berlin Germany:011 49 30 260050, EMAIL: customerservice@deguyter.de, INTERNET: http://www.degruyter.de/, Fax: 011 49 30 26005338",
}